News and Insights

Modeling and Analytics

Engaging in Value-Based Contracts with Providers

Pharmaceutical Executive

With spiraling cost inflation and outcomes that lag many other developed economies, the US government’s healthcare insurance authority (CMS), is driving reform aimed at better quality and lower cost, and private payers are following suit. Both state and private payers are moving toward alternative payment models, like value-based payments, that…

Considerations for Risk Sharing Agreements

eyeforpharma

In a recent move that garnered considerable attention, Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the US, announced a plan that would link the price of some cancer drugs to their real-world performance.1 Although this isn’t the first time that an alternative pricing model for drugs has…

Key Considerations for Successful Data Collaborations

eyeforpharma

With the recent explosion of healthcare data in the U.S. as well as the announcement of several well-publicized partnerships between manufacturers and providers or payers, the emergence of data collaborations is currently one of the hottest trends in healthcare. It’s no secret that the pharmaceutical industry is facing a series…

The Silver Tsunami

Physician Leadership Journal

There is a looming population group poised to impact the US healthcare system with a voracious appetite for healthcare. The group has been dubbed the ‘silver tsunami’– a name that our research shows first appeared in a 2002 paper by University of Nevada, Reno professor Mary Finn Maples. So how…

Using Data to Link Product Value and Price

eyeforpharma

While the pharmaceutical and medical device industries have found themselves in a turbulent healthcare marketplace rife with changing regulations, new competitive challenges, and increasing pricing pressures, the end goal for manufacturers remains the same — product reimbursement and optimal pricing.  These two terms are regularly linked together because reimbursement is…

Making the Transition from Volume to Value

AHA’s Center for Healthcare Governance

With healthcare costs now claiming nearly 20% of GDP and quality lagging behind benchmarks, the urgent need to ensure better care at lower cost is increasingly plain to healthcare leadership. Providers at all levels need to begin the shift from a volume-based model to a value-based one that offers the…